APP and Alzheimer disease: Chronic CBD treatment (20 mg/kg and 50 mg/kg) reverses social recognition memory deficits of <i>APP<sub>Swe</sub>/PS1∆E9</i> (<i>APP/PS1</i>) transgenic mice; however, it does not produce effects on AD-relevant brain pathology.